Major urinary proteins 11 and 8 Polyclonal Antibody |
42636-100ul |
SAB |
100ul |
EUR 399.6 |
Igg Antibody Laboratories manufactures the igg major serum antibody reagents distributed by Genprice. The Igg Major Serum Antibody reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact igg antibody. Other Igg products are available in stock. Specificity: Igg Category: Major Group: Serum Antibody
Goat Serum antibody |
Fitzgerald |
10 ml |
EUR 159.6 |
Description: Guinea pig polyclonal Goat Serum antibody |
Goat Serum antibody |
Fitzgerald |
10 ml |
EUR 159.6 |
Description: Guinea pig polyclonal Goat Serum antibody |
Serum Albumin Antibody |
SAB |
100ul |
EUR 399.6 |
Serum Antibody information
Major Vault Protein (MVP) Antibody |
abx033927-80l |
Abbexa |
80 µl |
EUR 343.2 |
|
Major Vault Protein (MVP) Antibody |
abx032736-400ul |
Abbexa |
400 ul |
EUR 627.6 |
|
Major Vault Protein (MVP) Antibody |
abx032736-80l |
Abbexa |
80 µl |
EUR 343.2 |
|
Major Basic Protein (MBP) Antibody |
20-abx101773 |
Abbexa |
-
EUR 493.20
-
EUR 159.60
-
EUR 1378.80
-
EUR 678.00
-
EUR 376.80
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Major Basic Protein (MBP) Antibody |
20-abx101774 |
Abbexa |
-
EUR 510.00
-
EUR 159.60
-
EUR 1412.40
-
EUR 693.60
-
EUR 393.60
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Major Basic Protein (MBP) Antibody |
20-abx101775 |
Abbexa |
-
EUR 510.00
-
EUR 159.60
-
EUR 1412.40
-
EUR 693.60
-
EUR 393.60
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Major Basic Protein (MBP) Antibody |
20-abx101776 |
Abbexa |
-
EUR 393.60
-
EUR 994.80
-
EUR 526.80
-
EUR 184.80
-
EUR 309.60
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
Major Vault Protein (MVP) Antibody |
20-abx129080 |
Abbexa |
-
EUR 493.20
-
EUR 159.60
-
EUR 1378.80
-
EUR 678.00
-
EUR 376.80
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Major Basic Protein (MBP) Antibody |
20-abx132036 |
Abbexa |
-
EUR 393.60
-
EUR 978.00
-
EUR 510.00
-
EUR 184.80
-
EUR 309.60
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
Major Basic Protein (MBP) Antibody |
20-abx132037 |
Abbexa |
-
EUR 410.40
-
EUR 1045.20
-
EUR 543.60
-
EUR 184.80
-
EUR 326.40
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
Major capsid protein L1 antibody |
70R-15488 |
Fitzgerald |
100 ug |
EUR 392.4 |
Description: Rabbit polyclonal Major capsid protein L1 antibody |
Major Vault Protein (MVP) Antibody |
20-abx001613 |
Abbexa |
-
EUR 493.20
-
EUR 710.40
-
EUR 218.40
-
EUR 376.80
|
- 100 ul
- 200 ul
- 20 ul
- 50 ul
|
|
Major Vault Protein Antibody / MVP |
F54845-0.08ML |
NSJ Bioreagents |
0.08 ml |
EUR 140.25 |
Description: MVP, the major vault protein, is a lung resistance-related protein. Vaults are multi-subunit structures that may be involved in nucleo-cytoplasmic transport. This protein mediates drug resistance, perhaps via a transport process. It is widely distributed in normal tissues, and overexpressed in multidrug-resistant cancer cells. The protein overexpression is a potentially useful marker of clinical drug resistance. |
Major Vault Protein Antibody / MVP |
F54845-0.4ML |
NSJ Bioreagents |
0.4 ml |
EUR 322.15 |
Description: MVP, the major vault protein, is a lung resistance-related protein. Vaults are multi-subunit structures that may be involved in nucleo-cytoplasmic transport. This protein mediates drug resistance, perhaps via a transport process. It is widely distributed in normal tissues, and overexpressed in multidrug-resistant cancer cells. The protein overexpression is a potentially useful marker of clinical drug resistance. |
MVP Antibody / Major Vault Protein |
V3042-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
Description: Recognizes a protein of 104kDa-110kDa, characterized as major vault protein (MVP). Vaults are large ribonucleoprotein particles (RNPs) present in all eukaryotic cells. They have a complex morphology, including several small molecules of RNA, but a single protein species. The MVP accounts for >70% of their mass. Their shape is reminiscent of the nucleopore central plug. Treatment of cells with estradiol increases the amount of MVP in nuclear extract. The hormone-dependent interaction of vaults with ER is prevented in vitro by sodium molybdate. Antibodies to estrogen, progesterone and glucocorticoid receptors are able to co-immunoprecipitate the MVP. MVP is overexpressed in many neoplastic tissues and cell lines. Expression of MVP predicts a poor response to chemotherapy. |
MVP Antibody / Major Vault Protein |
V3042-20UG |
NSJ Bioreagents |
20 ug |
EUR 153.3 |
Description: Recognizes a protein of 104kDa-110kDa, characterized as major vault protein (MVP). Vaults are large ribonucleoprotein particles (RNPs) present in all eukaryotic cells. They have a complex morphology, including several small molecules of RNA, but a single protein species. The MVP accounts for >70% of their mass. Their shape is reminiscent of the nucleopore central plug. Treatment of cells with estradiol increases the amount of MVP in nuclear extract. The hormone-dependent interaction of vaults with ER is prevented in vitro by sodium molybdate. Antibodies to estrogen, progesterone and glucocorticoid receptors are able to co-immunoprecipitate the MVP. MVP is overexpressed in many neoplastic tissues and cell lines. Expression of MVP predicts a poor response to chemotherapy. |
MVP Antibody / Major Vault Protein |
V3042SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
Description: Recognizes a protein of 104kDa-110kDa, characterized as major vault protein (MVP). Vaults are large ribonucleoprotein particles (RNPs) present in all eukaryotic cells. They have a complex morphology, including several small molecules of RNA, but a single protein species. The MVP accounts for >70% of their mass. Their shape is reminiscent of the nucleopore central plug. Treatment of cells with estradiol increases the amount of MVP in nuclear extract. The hormone-dependent interaction of vaults with ER is prevented in vitro by sodium molybdate. Antibodies to estrogen, progesterone and glucocorticoid receptors are able to co-immunoprecipitate the MVP. MVP is overexpressed in many neoplastic tissues and cell lines. Expression of MVP predicts a poor response to chemotherapy. |